Multifunctional Nano Immunostimulant: Overcoming Immunosuppressive Microenvironment for Antitumor Immunotherapy
Advanced Science · 2025
DOI: 10.1002/advs.202517480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Guanhong Guo und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shandong Second Medical University, Weifang, 261053, P. R. China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy, Adjuvants, Immunologic, Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, Yellow River Delta industry-leading talents, Shandong Province Medical and Health Science and Technology Project.
Abstract (Originalsprache)
Antitumor immunotherapy has become a pillar therapy by activating the immune system to recognize and attack tumor cells. Yet its efficacy is limited by the immunosuppressive tumor microenvironment (TME) and related mechanisms like hypoxia, high glutathione (GSH) expression, and immune evasion. Due to TME complexity and tumor heterogeneity, monotherapy struggles to modulate immunosuppressive factors for potent results. To solve this, this work develops a multifunctional immune stimulator (3IZH), which can simultaneously boost immunity, downregulate GSH, and alleviate hypoxia. In weakly acidic TME, it releases photosensitizer (3ICy5) and Fe ions. Fe ions consume GSH and relieve hypoxia via redox reactions and hydrogen peroxide decomposition. 3ICy5 accumulates in the endoplasmic reticulum (ER), produces ROS, induces severe ER stress and DAMPs release, triggering immunogenic cell death (ICD). Fe ions and ROS also reduce glutathione peroxidase 4 (GPX4), causing ferroptosis. ICD and ferroptosis activate T cell infiltration to restructure TME. Combined with HIF‐1α inhibitor digoxin, 3IZH further reduces HIF‐1α resistance, enhances immune cell infiltration, and shows satisfying efficacy in bilateral tumor‐bearing mice. The regulatory effect of the immune‐suppressive TME, the remarkable therapeutic effect, as well as the safety profile, together indicate the potential of the multifunctional immune stimulator design strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shandong Second Medical University, Weifang, 261053, P. R. China.
- Weifang University of Science and Technology, Weifang, 262700, P. R. China.
- Harway Pharma (Weifang) Co., Ltd, Weifang, 262700, P. R. China.
- State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024, P. R. China.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, NY, 11439, USA.
ORCID-Profile: Wenda Zhong
Förderung
- Natural Science Foundation of Shandong Province
- Yellow River Delta industry-leading talents
- Shandong Province Medical and Health Science and Technology Project
Zitieren
APA
Guo, G., Zhong, W., Zhao, H., An, Y., Dong, X., Li, Z., Qin, S., Xu, G., Yue, X., Wang, X., Sun, W., Chen, Z. S., Song, W., Wei, L., & Li, F. (2025). Multifunctional Nano Immunostimulant: Overcoming Immunosuppressive Microenvironment for Antitumor Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202517480
Vancouver
Guo G, Zhong W, Zhao H, An Y, Dong X, Li Z, et al. Multifunctional Nano Immunostimulant: Overcoming Immunosuppressive Microenvironment for Antitumor Immunotherapy. Advanced Science. 2025. doi:10.1002/advs.202517480
BibTeX
@article{Guo2025,
author = {Guo, Guanhong and Zhong, Wenda and Zhao, Huishuang and An, Yueying and Dong, Xinyu and Li, Zhengbo and Qin, Shuangfeng and Xu, Guangzhao and Yue, Xiangguo and Wang, Xudong and Sun, Wen and Chen, Zhe-Sheng and Song, Weiguo and Wei, Liuya and Li, Fahui},
title = {Multifunctional Nano Immunostimulant: Overcoming Immunosuppressive Microenvironment for Antitumor Immunotherapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202517480}
}
EUVIMED